The use of antimetabolites with trabeculectomy: a critical appraisal.
OBJECTIVE
To examine why most ophthalmologists routinely use mitomycin C or 5-fluorouracil (antimetabolites) in association with filtering surgery for glaucoma.


METHODS
Critical analysis of seven medical, social and economic trends.


RESULTS
The rapid acceptance of the adjunctive use of antimetabolites at the time of filtration surgery may be explained by reasons other than anticipated increase in the "success" of glaucoma surgery.


CONCLUSIONS
The use of antimetabolites in conjuction with filtering glaucoma surgery may be at least partially a consequence of changing medical-social-economic factors, rather than solely a desire on the part of physicians to improve the "success" of glaucoma surgery. This may indicate a need to reevaluate the proper place of antimetabolites in association with filtration surgery.
Spaeth
G L
GL
Mutlukan
E
E
D000963:Antimetabolites / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003695:Delivery of Health Care / Q000191:economics; D005472:Fluorouracil / Q000627:therapeutic use*; D005901:Glaucoma / Q000188:drug therapy* / Q000191:economics / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure; D016685:Mitomycin / Q000627:therapeutic use*; D014130:Trabeculectomy
D000963:Antimetabolites; D016685:Mitomycin; D005472:Fluorouracil